Proceedings of the Japan Academy, Series B. Physical and Biological Sciences 2011-01-01

Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.

Naomi Haruta, Hideaki Iizuka, Kana Ishii, Shunsuke Yoshihara, Hideaki Ichiba, Takeshi Fukushima

Index: Proc. Jpn. Acad.,. Ser. B, Phys. Biol. Sci. 10th ed., 87 , 641-8, (2011)

Full Text: HTML

Abstract

A determination method for 3-methylpyrazole-5-carboxylic acid (MPC), an inhibitor of D-amino acid oxidase (DAAO), in rat plasma was developed by using high-performance liquid chromatography-mass spectrometry (LC-MS). The structural isomer of MPC, 3-methylpyrazole-4-carboxylic acid, was used as an internal standard, and the intra- and inter-day accuracies and precisions were satisfactory for the determination of plasma MPC.Next, the LC-MS method was applied to determine the plasma MPC concentration in ketamine (Ket)-treated rats after intraperitoneal administration of MPC (5.0 or 50 mg·kg(-1)). The C(max) value of plasma MPC concentration in the Ket-treated rats was significantly higher than that in the control group when a high dose of MPC (50 mg·kg(-1)) was administered. In addition, it was found that plasma D-tryptophan (D-Trp) concentration in Ket-treated rats administered D-Trp was not significantly increased by MPC, suggesting that the DAAO-inhibitory effect of MPC is attenuated in Ket-treated rats.


Related Compounds

Related Articles:

A high-performance liquid chromatography assay with a triazole-bonded column for evaluation of d-amino acid oxidase activity.

2016-03-01

[Biomed. Chromatogr. 30 , 384-9, (2016)]

More Articles...